Open Science Research Excellence

ICNOT 2020 : International Conference on Novel Oncology Therapeutics

Sydney, Australia
January 30 - 31, 2020

Conference Code: 20AU01ICNOT

Conference Proceedings

All submitted conference papers will be blind peer reviewed by three competent reviewers. The peer-reviewed conference proceedings are indexed in the Open Science Index, Google Scholar, Semantic Scholar, Zenedo, OpenAIRE, BASE, WorldCAT, Sherpa/RoMEO, and other index databases. Impact Factor Indicators.

Special Journal Issues

ICNOT 2020 has teamed up with the Special Journal Issue on Novel Oncology Therapeutics. A number of selected high-impact full text papers will also be considered for the special journal issues. All submitted papers will have the opportunity to be considered for this Special Journal Issue. The paper selection will be carried out during the peer review process as well as at the conference presentation stage. Submitted papers must not be under consideration by any other journal or publication. The final decision for paper selection will be made based on peer review reports by the Guest Editors and the Editor-in-Chief jointly. Selected full-text papers will be published online free of charge.

Conference Sponsor and Exhibitor Opportunities

The Conference offers the opportunity to become a conference sponsor or exhibitor. To participate as a sponsor or exhibitor, please download and complete the Conference Sponsorship Request Form.

Important Dates

Abstracts/Full-Text Paper Submission Deadline   August 29, 2019
Notification of Acceptance/Rejection   September 10, 2019
Final Paper (Camera Ready) Submission & Early Bird Registration Deadline   December 31, 2019
Conference Dates   January 30 - 31, 2020

Important Notes

Please ensure your submission meets the conference's strict guidelines for accepting scholarly papers. Downloadable versions of the check list for Full-Text Papers and Abstract Papers.

Please refer to the Paper Submission GUIDE before submitting your paper.

Selected Conference Papers

1) Non-Melanoma Skin Cancer in Ha’il Region in the Kingdom of Saudi Arabia: A Clinicopathological Study
Laila Seada, Nouf Al Gharbi, Shaimaa Dawa
2) Assessment of Predictive Confounders for the Prevalence of Breast Cancer among Iraqi Population: A Retrospective Study from Baghdad, Iraq
Nadia H. Mohammed, Anmar Al-Taie, Fadia H. Al-Sultany
3) In vitro Study of Laser Diode Radiation Effect on the Photo-Damage of MCF-7 and MCF-10A Cell Clusters
A. Dashti, M. Eskandari, L. Farahmand, P. Parvin, A. Jafargholi
4) Thermalytix: An Advanced Artificial Intelligence Based Solution for Non-Contact Breast Screening
S. Sudhakar, Geetha Manjunath, Siva Teja Kakileti, Himanshu Madhu
5) Comparative Evaluation of Accuracy of Selected Machine Learning Classification Techniques for Diagnosis of Cancer: A Data Mining Approach
Rajvir Kaur, Jeewani Anupama Ginige
6) Hypothesis of a Holistic Treatment of Cancer: Crab Method
Devasis Ghosh
7) Quality of Life Assessment across the Cancer Continuum: Understanding the Role of an Exercise Rehabilitation Programme
Bernat-Carles Serdà Ferrer, Arantza Del Valle Gómez
8) Assessment of Drug Delivery Systems from Molecular Dynamic Perspective
M. Rahimnejad, B. Vahidi, B. Ebrahimi Hoseinzadeh, F. Yazdian, P. Motamed Fath, R. Jamjah
9) Identification of Disease Causing DNA Motifs in Human DNA Using Clustering Approach
G. Tamilpavai, C. Vishnuppriya
10) MITOS-RCNN: Mitotic Figure Detection in Breast Cancer Histopathology Images Using Region Based Convolutional Neural Networks
Siddhant Rao
11) miR-200c as a Biomarker for 5-FU Chemosensitivity in Colorectal Cancer
Rezvan Najafi, Korosh Heydari, Massoud Saidijam
12) Silicon-To-Silicon Anodic Bonding via Intermediate Borosilicate Layer for Passive Flow Control Valves
Luc Conti, Dimitry Dumont-Fillon, Harald van Lintel, Eric Chappel
13) An Alternative and Complementary Medicine Method in Vulnerable Pediatric Cancer Patients: Yoga
Ç. Erdoğan, T. Turan
14) Grade and Maximum Tumor Dimension as Determinants of Lymphadenectomy in Patients with Endometrioid Endometrial Cancer (EEC)
Ali A. Bazzi, Ameer Hamza, Riley O’Hara, Kimberly Kado, Karen H. Hagglund, Lamia Fathallah, Robert T. Morris
15) Absorbed Dose Estimation of 177Lu-DOTATOC in Adenocarcinoma Breast Cancer Bearing Mice
S. Zolghadri, M. Mousavi-Daramoroudi, H. Yousefnia, F. Abbasi-Davani

Similar conferences about Pharmacological and Pharmaceutical Sciences